CIK 0001720893
- Non-accelerated filer
- Smaller reporting company
BioXcel Therapeutics, Inc.
Sign in to watch- Ticker
- BTAIQ
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 821386754
- Phone
- +1 203-643-8060
- Business address
- 555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-03 | Wiley Matthew T. Chief Commercial Officer | Sale 10b5-1 | −6,272 | $0.55 | $3K | 19,011 |
| 2024-09-17 | Wiley Matthew T. Chief Commercial Officer | Grant or award 10b5-1 | +21,250 | 25,283 | ||
| 2024-09-16 | Wiley Matthew T. Chief Commercial Officer | Sale 10b5-1 | −215 | $0.69 | $149 | 4,033 |
| 2024-09-15 | Wiley Matthew T. Chief Commercial Officer | Exercise or conversion 10b5-1 | +750 | 4,248 | ||
| 2024-09-15 | Wiley Matthew T. Chief Commercial Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −750 | 7,500 | ||
| 2024-07-22 | Wiley Matthew T. | Grant or award · Stock Option (right to buy) | +1,875 | 1,875 | ||
| 2024-06-17 | Wiley Matthew T. Chief Commercial Officer | Sale 10b5-1 | −244 | $1.26 | $308 | 3,498 |
| 2024-06-15 | Wiley Matthew T. Chief Commercial Officer | Exercise or conversion · Restricted Stock Units | −750 | 8,250 | ||
| 2024-06-15 | Wiley Matthew T. Chief Commercial Officer | Exercise or conversion 10b5-1 | +750 | 3,742 | ||
| 2024-06-15 | Wiley Matthew T. Chief Commercial Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | +750 | 8,250 | ||
| 2024-04-04 | Wiley Matthew T. CHIEF COMMERCIAL OFFICER | Sale 10b5-1 | −1,008 | $2.64 | $3K | 2,992 |
| 2024-03-15 | Wiley Matthew T. CHIEF COMMERCIAL OFFICER | Exercise or conversion 10b5-1 | +3,000 | 3,000 | ||
| 2024-03-15 | Wiley Matthew T. CHIEF COMMERCIAL OFFICER | Exercise or conversion · Restricted Stock Units 10b5-1 | +3,000 | 9,000 | ||
| 2023-03-15 | Wiley Matthew T. CHIEF COMMERCIAL OFFICER | Grant or award · Restricted Stock Units | +12,000 | 12,000 | ||
| 2023-03-15 | Wiley Matthew T. CHIEF COMMERCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +36,000 | 36,000 | ||
| 2022-01-17 | Wiley Matthew T. CHIEF COMMERCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +85,000 | 85,000 |
Page 1 of 1 · 16 trades